✦ LIBER ✦

Serious Adverse Events During Ruxolitinib Treatment Discontinuation in Patients With Myelofibrosis

✍ Scribed by Tefferi, Ayalew; Pardanani, Animesh

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of Cytopenias With Ruxolitini

✍ Verstovsek, Srdan; Quintas-Cardama, Alfonso; Mesa, Ruben A.; Gupta, Vikas; Masca 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 57 KB

Clinical adverse events observed during

✍ Abitbol, J.-L.; Weber, F.; Mathé, H.; Scherter, B. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Low impact of cardiovascular adverse eve

✍ Luigi Gugliotta; Alessia Tieghi; Giovanni Tortorella; Potito Rosario Scalzulli; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 289 KB

High Incidence of Discontinuations Due t

✍ Jain, Rupali; Chan, Jeannie D.; Rogers, Lisa; Dellit, Timothy H.; Lynch, John B. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

Occurrence and Care of an Obese Patient

✍ Michele Carron; Ulderico Freo; Carlo Ori 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 69 KB

Serious adverse drug events in inflixima

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB